Characterization of immunoliposomes as delivery vehicles for the Rac inhibitor Ehop-016 in HER2 type breast cancer

被引：0
|
作者：
Rivera-Robles, Michael J.
Vivas-Mejia, Pablo E.
Castillo-Pichardo, Linette
Vlaar, Cornelis
Hernandez, Eliud
Dharmawardhane, Suranganie
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-2197
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2197
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Characterization of an improved derivative of the Rac/PAK inhibitor EHop-016 in breast cancer
    Castillo-Pichardo, Linette
    Humphries-Bickley, Tessa
    Forrestier-Roman, Ingrid
    Borrero-Garcia, Luis
    Melendez, Fabiola Pagan
    Hernandez, Eliud
    Vlaar, Cornelis
    Cubano, Luis A.
    Dharmawardhane, Surangani
    CANCER RESEARCH, 2016, 76
  • [2] Characterization of EHop-016, Novel Small Molecule Inhibitor of Rac GTPase
    Montalvo-Ortiz, Brenda L.
    Castillo-Pichardo, Linette
    Hernandez, Eliud
    Humphries-Bickley, Tessa
    De La Mota-Peynado, Alina
    Cubano, Luis A.
    Vlaar, Cornelis P.
    Dharmawardhane, Suranganie
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (16) : 13228 - 13238
  • [3] RAC1-Amplified and RAC1-A159V Hotspot-Mutated Head and Neck Cancer Sensitive to the Rac Inhibitor EHop-016 In Vivo: A Proof-of-Concept Study
    Chan, Helen Hoi Yin
    Ngan, Hoi-Lam
    Ng, Yuen-Keng
    Law, Chun-Ho
    Poon, Peony Hiu Yan
    Chan, Ray Wai Wa
    Lau, Kwok-Fai
    Piao, Wenying
    Li, Hui
    Wang, Lan
    Chan, Jason Ying Kuen
    Su, Yu-Xiong
    Yeung, Thomas Chun Kit
    Wong, Eileen
    Li, Angela Wing Tung
    Verhoeft, Krista Roberta
    Liu, Yuchen
    He, Yukai
    Tsui, Stephen Kwok-Wing
    Mills, Gordon B.
    Lui, Vivian Wai Yan
    CANCERS, 2025, 17 (03)
  • [4] Characterization of immunoliposomes for HER2-targeted delivery of the dual Rac/Cdc42 inhibitor MBQ-167
    Velazquez-Vega, Luis
    Dharmawardhane, Suranganie
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (03) : S116 - S117
  • [5] Characterization of immunoliposomes for HER2-targeted delivery of the dual Rac/Cdc42 inhibitor MBQ-167
    Velazquez, Luis E.
    Dharmawardhane, Suranganie
    CANCER RESEARCH, 2023, 83 (07)
  • [6] Efficacy and delivery strategies of the dual Rac/Cdc42 inhibitor MBQ-167 in HER2 overexpressing breast cancer
    Velazquez-Vega, Luis E.
    Rivera-Robles, Michael
    Sanchez-Alvarez, Annelis O.
    Vivas-Mejia, Pablo E.
    Aponte-Reyes, Miciely
    Cruz-Collazo, Ailed M.
    Grafals-Ruiz, Nilmary
    Dorta-Estremera, Stephanie
    Hernandez-O'Farrill, Eliud
    Vlaar, Cornelis P.
    Dharmawardhane, Suranganie
    TRANSLATIONAL ONCOLOGY, 2024, 44
  • [7] Specific gene delivery to Her-2+breast cancer cells using immunoliposomes
    Kullberg, M.
    McCarthy, R.
    Anchordoquy, T. J.
    CANCER RESEARCH, 2013, 73
  • [8] Development and Evaluation of Tri-Functional Immunoliposomes for the Treatment of HER2 Positive Breast Cancer
    Tanaya Vaidya
    Robert M. Straubinger
    Sihem Ait-Oudhia
    Pharmaceutical Research, 2018, 35
  • [9] Characterization of HER2 positive breast cancer in Tunisia
    Yaiche, R.
    Houcine, Y.
    Saidi, E.
    Saadallah, F.
    Kamoun, S.
    Meddeb, K.
    Driss, M.
    VIRCHOWS ARCHIV, 2024, 485 : S210 - S210
  • [10] Development and Evaluation of Tri-Functional Immunoliposomes for the Treatment of HER2 Positive Breast Cancer
    Vaidya, Tanaya
    Straubinger, Robert M.
    Ait-Oudhia, Sihem
    PHARMACEUTICAL RESEARCH, 2018, 35 (05)
12345